Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Myocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer COVID-19 vaccine)
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford
KoreaMed Synapse
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
While rare, myocarditis after COVID-19 vaccination is more common in young men
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
JCM | Free Full-Text | Epidemiological Impact of Myocarditis
COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology
Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet
The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood | Heart
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Presentation - Update on myocarditis following
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis - ScienceDirect
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy - ScienceDirect
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure
Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis | Journal of the American College of Cardiology
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis | medRxiv
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to November 21, 202